Mirae Asset Global Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$133K Buy
3,652
+557
+18% +$20.3K ﹤0.01% 1098
2025
Q1
$117K Buy
3,095
+18
+0.6% +$681 ﹤0.01% 1104
2024
Q4
$134K Sell
3,077
-256
-8% -$11.1K ﹤0.01% 1109
2024
Q3
$181K Buy
3,333
+851
+34% +$46.3K ﹤0.01% 1098
2024
Q2
$103K Sell
2,482
-228,285
-99% -$9.46M ﹤0.01% 1137
2024
Q1
$8.76M Buy
230,767
+122,412
+113% +$4.65M 0.02% 689
2023
Q4
$5.18M Sell
108,355
-102,613
-49% -$4.91M 0.01% 883
2023
Q3
$7.52M Buy
210,968
+18,845
+10% +$672K 0.02% 725
2023
Q2
$8.87M Sell
192,123
-41,033
-18% -$1.89M 0.02% 702
2023
Q1
$9.35M Buy
233,156
+8,479
+4% +$340K 0.02% 665
2022
Q4
$10.4M Buy
224,677
+92,185
+70% +$4.27M 0.03% 584
2022
Q3
$5.49M Buy
132,492
+4,333
+3% +$179K 0.01% 768
2022
Q2
$7.65M Sell
128,159
-8,747
-6% -$522K 0.02% 698
2022
Q1
$9.94M Sell
136,906
-23,821
-15% -$1.73M 0.02% 668
2021
Q4
$13.5M Buy
160,727
+37,320
+30% +$3.14M 0.03% 582
2021
Q3
$11.1M Buy
123,407
+21,012
+21% +$1.9M 0.03% 605
2021
Q2
$9.76M Buy
102,395
+14,134
+16% +$1.35M 0.03% 642
2021
Q1
$10M Buy
88,261
+33,663
+62% +$3.83M 0.03% 529
2020
Q4
$7.56M Buy
54,598
+10,262
+23% +$1.42M 0.03% 568
2020
Q3
$3.64M Buy
44,336
+12,691
+40% +$1.04M 0.02% 614
2020
Q2
$2.48M Buy
31,645
+10,403
+49% +$814K 0.01% 657
2020
Q1
$943K Buy
21,242
+2,248
+12% +$99.8K 0.01% 845
2019
Q4
$811K Buy
18,994
+8,185
+76% +$349K 0.01% 1041
2019
Q3
$463K Buy
10,809
+7,022
+185% +$301K ﹤0.01% 1186
2019
Q2
$241K Buy
+3,787
New +$241K ﹤0.01% 1330